Novavax scheduled late-stage trial of COVID-19 vaccine in United States Kumar Jeetendra | December 29, 2020 Novavax Inc has begun a large late-stage study of its experimental COVID-19 vaccine in the United States, the drug developer said on Monday, after delaying the trial twice due to issues in scaling up the manufacturing process. It will enroll up to 30,000 volunteers across about 115 sites in the United States and Mexico, with …
Britain ought to vaccinate 2 million every week to prevent 3rd COVID-19 wave: Study Kumar Jeetendra | December 29, 2020 Britain must vaccinate two million people a week to avoid a third wave of the coronavirus outbreak, a study by the London School of Hygiene and Tropical Medicine (LSHTM) has concluded. The UK has had over 71,000 deaths from the coronavirus and has recorded over 2.3 million cases of COVID-19 infections as of late Monday, …
Six cases of new mutant corona strain detected in India Kumar Jeetendra | December 29, 2020 Six cases of a mutant strain of coronavirus that first surfaced in the united kingdom, have been discovered in the country. The new strain is believed to be 70 percent more infectious, but doctors have said there isn’t any reason yet to believe that it is more lethal or will not be controlled by means …
FDA favors first conventional glucagon for injection to treat extreme hypoglycemia Kumar Jeetendra | December 29, 2020 Today, the U.S. Food and Drug Administration approved the first generic of glucagon for injection USP, 1 mg/vial packed in an emergency kit, for the treatment of severe hypoglycemia (very low blood sugar), which may occur in patients with diabetes mellitus. The drug is also indicated as a diagnostic aid in the radiologic examination of …
Enormous transporter protein dysfunction related with schizophrenia Kumar Jeetendra | December 29, 2020 Researchers have suspected mutations in a cellular cholesterol transport protein are associated with psychiatric disorders, but have found it hard to show this and to pinpoint how it happens. Currently, Kazumitsu Ueda of Kyoto University’s Institute for Integrated Cell-Material Sciences (iCeMS) and colleagues in Japan have provided evidence that mice with disrupted ABCA13 protein demonstrate …
Will COVID-19 immunizations work on the new Covid variant? Kumar Jeetendra | December 30, 2020 Germany | Germans enjoyed a mostly relaxed summer with several restrictions increased, the dividend of a quick response to the initial coronavirus outbreak and a dependence on early and widespread testing that won wide praise. It brought the amount of daily COVID-19 cases down from a peak of more than 6,000 in late March to …
Poisonous pesticide transformed into treatment against antibiotic-resistant bacteria Kumar Jeetendra | December 30, 2020 They are used as pesticides and fungicides. However, these substances could be poisonous to humans and cause mutations. As they aren’t frequently used, there’s little data about them in the medicinal chemistry literature. However, it has been suggested recently that the groups of substances that are traditionally avoided can help to fight pathogenic bacteria. Yet, …
Zydus Cadila gets DCGI gesture for NAFLD drug in India Kumar Jeetendra | December 30, 2020 New Delhi, Dec 30 (PTI) Drug firm Zydus Cadila on Wednesday said it has received approval from the Drug Controller General of India (DCGI) for Saroglitazar Mg, used for the treatment of non-alcoholic fatty liver disease (NAFLD), in the nation. Zydus Cadila explained the prevalence of NAFLD in India is estimated to be nearly 25-30 …
Sero-Surveillance is Essential for Monitoring of COVID-19 Pandemic and Safety at Workplaces to Revive Economy Kumar Jeetendra | December 31, 2020 Sero-surveillance is important for developing a comprehensive management strategy to counteract COVID-19 pandemic, by restoring employee strength at workplaces and also for evaluating the impact of vaccination programs by prioritization of healthcare workers, essential service providers and vulnerable groups for receiving the vaccines on basis of their immune status. Towards this, the Confederation of Indian …
Moderna COVID-19 antibody shows 94.1% adequacy in preliminary: Study Kumar Jeetendra | December 31, 2020 Results from the primary analysis of the ongoing phase 3 clinical trial of US biotechnology company Moderna’s COVID-19 vaccine have revealed 94.1 per cent effectiveness of the therapeutic in preventing symptomatic infections and severe illness, according to a peer-reviewed study. The analysis, published on Wednesday in The New England Journal of Medicine, found that among …
Russia to convey more than 1 million Sputnik V shots at home by year-end: Minister Kumar Jeetendra | December 31, 2020 Russia will have supplied more than 1 million doses of its COVID-19 vaccine Sputnik V to its own national inoculation programme by the end of the year, a government minister said on Wednesday. Russia, which started rolling out the vaccine in early December, has thus far produced more than 2 million doses in total, Industry …
Older adults, minorities and individuals with lower salaries face disparities in telemedicine use Kumar Jeetendra | December 31, 2020 After”COVID-19,” the word which most people will remember best from 2020 is very likely to be”social distancing.” While it most commonly applied to social gatherings with family and friends, it has changed how many receive medical attention. However, the COVID-19 pandemic, particularly in the spring of 2020, required increased use of virtual or telephone call …
